You searched for metabolic diseases - Page 18 of 64

News and Trends 9 May 2023

Gilead boosts oncology pipeline with XinThera acquisition

…body’s immune response in inflammatory diseases, both of which may improve outcomes for people living with these diseases,” said Flavius Martin, executive vice president, research, at Gilead Sciences. “Guided by…

May 9, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 17 May 2023

Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases

…cause serious neurological and neuromuscular diseases. “We are thrilled to work with the Prevail team to advance potential treatments for patients facing debilitating genetic diseases,” said Benjamin Oakes, chief executive…

May 17, 2023 - 3 minutesmins - By Jim Cornall

alchemyrefiner alchemymagic 1 37c41ba7 555f 4f93 ad44 39b31d752775 0

Podcast 15 Mar 2024

Reformulating psychedelics for neurodegenerative diseases

…psychiatric diseases. Table of contents About Terran Biosciences The company has built a CNS-focused, tech-enabled drug development platform, and is advancing late-stage assets. These include a neuroimaging software platform (now…

March 15, 2024 - 8 minutesmins - By Jim Cornall

News and Trends 15 Dec 2022

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

…major role in multiple related and often co-morbid diseases. These diseases include approved indications for Dupixent, such as atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP) and prurigo nodularis,…

December 15, 2022 - 5 minutesmins - By Jim Cornall

Best in Biotech 19 Sep 2024

Six immunology biotech companies revolutionizing immune treatments in 2024

…course in 2020, changing its name, selecting a new board, and shifting to a new focus of developing drugs to treat immunological diseases with high unmet medical needs. The company…

September 19, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 3 Mar 2023

Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor

…09 is a novel metabolic immune checkpoint inhibitor, for the treatment of patients with hematological malignancies who are diagnosed with a relapse after allogeneic stem cell transplant (SCT). LR 09…

March 3, 2023 - 3 minutesmins - By Jim Cornall

Podcast 16 Feb 2024

How does AI help drug discovery?

…with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases….

February 16, 2024 - 10 minutesmins - By Jim Cornall

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

…undisclosed targets for the treatment of other neuromuscular diseases, hence expanding its pipeline. The financing was led by investment company Jeito Capital, and other investors that took part include Novo…

November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…leverage FANA technology in cancer immunotherapy and other therapeutic areas. AUM LifeTech’s pipeline focuses on developing RNA silencing therapies for a variety of genetically defined diseases. The company also has…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 18 Jul 2023

Korro Bio and Frequency Therapeutics to merge

…the potential to advance genetic medicines beyond rare genetic diseases into larger patient populations with common diseases. About OPERA Korro Bio’s platform, OPERA (oligonucleotide promoted editing of RNA), builds on…

July 18, 2023 - 7 minutesmins - By Jim Cornall

Best in Biotech 27 Feb 2024

Japan’s ten hottest biotech companies in healthcare

…disease and type 2 diabetes. For this reason, the Japanese healthcare authorities are encouraging research into the treatment and prevention of these diseases, in addition to promoting the potential of…

February 27, 2024 - 12 minutesmins - By Jules Adam

News and Trends 19 Jan 2023

Hundreds of genetic discoveries from FinnGen study

New results from the FinnGen research consortium include previously unknown genetic risk factors for many debilitating diseases. These findings have potential to facilitate the development of new therapies. Since initiation…

January 19, 2023 - 4 minutesmins - By Jim Cornall

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Gilead boosts oncology pipeline with XinThera acquisition

Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases

Reformulating psychedelics for neurodegenerative diseases

European Commission approves Dupixent as first and only targeted prurigo nodularis medicine

Six immunology biotech companies revolutionizing immune treatments in 2024

Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor

How does AI help drug discovery?

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA

Eight companies spearheading Philadelphia’s biotech industry

Korro Bio and Frequency Therapeutics to merge

Japan’s ten hottest biotech companies in healthcare

Hundreds of genetic discoveries from FinnGen study

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!